Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA opens first offices in China

This article was originally published in The Gray Sheet

Executive Summary

U.S. agency opens offices in Beijing, Guangzhou and Shanghai, China, the week of Nov. 17 in a move approved by the U.S. State Department in March (1"The Gray Sheet" June 23, 2008, p. 5). The eight senior staffers selected to work there are inspectors and senior technical experts in foods, medicines and medical devices, HHS notes. "By having a presence in other parts of the world, we can work more closely with manufacturers and other governments, better share best practices and further ensure ... quality and safety," stated HHS Secretary Mike Leavitt, who along with FDA Commissioner Andrew von Eschenbach traveled to the three cities last week to meet with manufacturers and Chinese government officials to discuss policy and governance reforms aimed at improving the safety of food and medical products. HHS also is working to have an FDA presence in India, Europe, Latin America and the Middle East

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026818

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel